1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow APTO-253: new trials by email Literature Review of APTO-253 trials Research Report on APTO-253
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS APTO-253 - Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult | Phase 1 | Terminated | Aptose Biosciences Inc. | 21 | 2014-10-01 | 2022-08-22 |
Leukemia (1) · Leukemia, Myeloid, Acute (1) · Recurrence (1)
United States (1)